Artemsinin based combination treatment
Showing 26 - 50 of >10,000
Uncomplicated Plasmodium Falciparum Malaria Trial (Artemether-Lumefantrine-Amodiaquine (ALAQ), Artemether-Lumefantrine (AL),
Not yet recruiting
- Uncomplicated Plasmodium Falciparum Malaria
- Artemether-Lumefantrine-Amodiaquine (ALAQ)
- +2 more
- (no location specified)
Jul 20, 2023
Salivary Gland Cancer Trial (vedicitumomab (Edisil, RC48), vedicitumomab in combination with pyrrolizidine, RC48 in combination
Not yet recruiting
- Salivary Gland Cancer
- vedicitumomab (Edisil, RC48）
- +3 more
- (no location specified)
Jun 9, 2023
Gaucher Disease Type 1 Trial in Jerusalem (Enzyme replacement therapy for Gaucher disease in combination with altus care
Completed
- Gaucher Disease Type 1
- Enzyme replacement therapy for Gaucher disease in combination with altus care application
-
Jerusalem, IsraelHebrew university
Sep 18, 2023
NSCLC Trial in Pittsburgh (M1774, Cemiplimab)
Not yet recruiting
- Non-Small Cell Lung Cancer
-
Pittsburgh, PennsylvaniaUPMC Cancer Center
May 22, 2023
Osteoarthritis, Knee Arthritis Trial in Mugla (Telerehabilitation, Paper Based Rehabilitation)
Completed
- Osteoarthritis
- Knee Arthritis
- Telerehabilitation
- Paper Based Rehabilitation
-
Muğla, TurkeyMuğla Sıtkı Koçman Training and Research Hospital
Jul 20, 2022
Prostate Adenocarcinoma, Prostate Cancer, Localized Prostate Cancer Trial in San Francisco, Saint Louis (Atezolizumab,
Recruiting
- Prostate Adenocarcinoma
- +2 more
- Atezolizumab
- +2 more
-
San Francisco, California
- +1 more
Oct 8, 2022
Breast Cancer Trial in Marseille (M1774, Fulvestrant injection)
Not yet recruiting
- Breast Cancer
- M1774
- Fulvestrant injection
-
Marseille, FranceInstitut Paoli Calmettes
Aug 9, 2023
Liver and Biliary Cancer Patients Treated With PD-1 Combination
Active, not recruiting
- Hepatocellular Carcinoma
- Bile Duct Cancer
- [68Ga]FAPI PET/CT and [18F]FDG PET/CT
-
Beijing, ChinaDepartment of Nuclear Medicine, Peking Union Medical College Hop
Dec 14, 2022
Rectal Cancer Trial in Frankfurt (drug, radiation, procedure)
Recruiting
- Rectal Cancer
- Kineret 100 MG in 0.67 ML Prefilled Syringe
- +3 more
-
Frankfurt, GermanyUniversity Hospital Goethe University Frankfurt
Aug 23, 2022
Sepsis, Septic Shock, Hematologic Malignancy Trial (drug, behavioral, other)
Not yet recruiting
- Sepsis
- +4 more
- Aminoglycosides intervention
- +3 more
- (no location specified)
Jun 29, 2022
High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma, Stage 0a Bladder Cancer AJCC v8, Stage 0is Bladder Cancer AJCC v8
Not yet recruiting
- High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma
- +3 more
- PD-L1/IDO Peptide Vaccine
- Pembrolizumab
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Apr 24, 2023
NSCLC (NSCLC) Trial (Ociperlimab, Placebo, Tislelizumab)
Not yet recruiting
- Non-small Cell Lung Cancer (NSCLC)
- Ociperlimab
- +8 more
- (no location specified)
Mar 17, 2023
Depression Trial in Kampala (Healthy Diet, Mindfulness-based cognitive therapy (MBCT))
Not yet recruiting
- Depression
- Healthy Diet
- Mindfulness-based cognitive therapy (MBCT)
-
Kampala, Central Uganda, UgandaMakerere University
May 4, 2023
Urothelial Carcinoma Associated 1 RNA, Human Trial (Pembrolizumab, Cisplatin, Carboplatin)
Active, not recruiting
- Urothelial Carcinoma Associated 1 RNA, Human
- Pembrolizumab
- +3 more
- (no location specified)
Aug 18, 2022
Coronary Artery Disease, Diabetes, Metabolic Syndrome Trial in Storrs (Consume 2 eggs with spinach per day, Egg Subsitute with
Completed
- Coronary Artery Disease
- +2 more
- Consume 2 eggs with spinach per day
- Egg Subsitute with spinach per day
-
Storrs, ConnecticutDepartment of Nutritional Sciences
Nov 1, 2022
MDR-TB, Immunotherapy Trial in Shanghai (V?2Vd2 T lymphocyte-based immunotherapy, Treatment regimens for MDR-TB)
Recruiting
- MDR-TB
- Immunotherapy
- Vγ2Vδ2 T lymphocyte-based immunotherapy
- Treatment regimens for MDR-TB
-
Shanghai, China
- +1 more
Aug 8, 2022
SCLC,Extensive Stage Trial in Changchun (AK104 IV infusion;Chiauranib oral)
Not yet recruiting
- SCLC,Extensive Stage
- AK104 IV infusion；Chiauranib oral
-
Changchun, Jilin, ChinaJilin Province Cancer Hospital
Aug 16, 2022
Sedation Complication Trial in Kyiv (Propofol injection, Dexmedetomidine injection, Dexmedetomidine and Propofol)
Completed
- Sedation Complication
- Propofol injection
- +2 more
-
Kyiv, UkraineMedical Network Dobrobut
Mar 30, 2023
Heart Failure Trial (A combination of a provider-facing desktop and mobile application with a patient-facing mobile application)
Not yet recruiting
- Heart Failure
- A combination of a provider-facing desktop and mobile application with a patient-facing mobile application
- (no location specified)
Dec 2, 2022
Aging Trial in Greifswald (Anodal tDCS, Intensive cognitive training, Sham tDCS)
Recruiting
- Aging
- Anodal tDCS
- +2 more
-
Greifswald, GermanyUniversity Medicine Greifswald
Nov 3, 2022
NSCLC Stage IV Trial in Gauting (combination regimen tremelimumab /durvalumab, platinum-based chemo (SoC))
Withdrawn
- NSCLC Stage IV
- combination regimen tremelimumab /durvalumab
- platinum-based chemotherapy (SoC)
-
Gauting, GermanyAsklepios Fachkliniken München-Gauting
Sep 26, 2022
Biliary Tract Cancer Trial in Worldwide (Durvalumab, Gemcitabine monotherapy, Gemcitabine + cisplatin)
Not yet recruiting
- Biliary Tract Cancer
- Durvalumab
- +7 more
-
Orange, California
- +36 more
Mar 6, 2023